CRESEMBA is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Astellas Pharma Us, Inc.. The primary component is Isavuconazonium Sulfate.
| Product ID | 0469-0520_034e698e-c634-4372-9a9a-89ca83dc0a80 | 
| NDC | 0469-0520 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | CRESEMBA | 
| Generic Name | Isavuconazonium Sulfate | 
| Dosage Form | Capsule | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2015-11-04 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA207500 | 
| Labeler Name | Astellas Pharma US, Inc. | 
| Substance Name | ISAVUCONAZONIUM SULFATE | 
| Active Ingredient Strength | 100 mg/1 | 
| Pharm Classes | Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2023-12-31 | 
| Marketing Start Date | 2015-11-04 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA207500 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2015-11-04 | 
| Ingredient | Strength | 
|---|---|
| ISAVUCONAZONIUM SULFATE | 186 mg/1 | 
| SPL SET ID: | 8f7f73b8-586a-4df0-935f-fecd4696c16c | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0469-0420 | CRESEMBA | isavuconazonium sulfate | 
| 0469-0520 | CRESEMBA | isavuconazonium sulfate | 
| 0469-2860 | CRESEMBA | isavuconazonium sulfate | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  CRESEMBA  87380656  5363262 Live/Registered | Astellas US LLC 2017-03-22 | 
|  CRESEMBA  85967909  4532336 Live/Registered | Astellas Pharma Inc. 2013-06-24 |